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Assessing Syringe Exchange Program Access
among Persons Who Inject Drugs (PWID)
in the District of Columbia
Sean T. Allen, Monica S. Ruiz, and Jeff Jones
ABSTRACT Prior research has explored spatial access to syringe exchange programs

(SEPs) among persons who inject drugs (PWID), but these studies have been based on
limited data from short periods of time. No research has explored changes in spatial
access to SEPs among PWID longitudinally. The purpose of this research is to examine
spatial access to SEPs among PWID who accessed services at a SEP in Washington,
District of Columbia (DC), from 1996 to 2010. The geometric point distance
estimation technique was used to calculate the mean walking distance PWID traveled
from the centroid point of their zip code of home residence to the mobile exchange site
where they accessed SEP services. Analysis of variance (ANOVA) was used to examine
differences in walking distance measures by year. The results of this research suggest
that the distance DC PWID traveled to access SEP services remained relatively constant
(approximately 2.75 mi) from 2003 to 2008, but increased to just over 4 mi in 2010.
This research provides support for expanding SEP operations such that PWID have
increased access to their services. Increasing SEP accessibility may help resolve unmet
needs among injectors.
KEYWORDS Persons who inject drugs, HIV, Syringe exchange programs, Substance use,
Access

INTRODUCTION
Research has documented the public health utility of syringe exchange programs
(SEPs) for persons who inject drugs (PWID). SEPs are cost-effective, decrease the
incidence of HIV among injectors, and have not been shown to increase drug use,
crime, or presence of discarded syringes in neighborhoods.1–5 Beyond the provision
of sterile injection equipment, PWID may experience other beneﬁts while engaging
with SEPs; for example, these programs may provide referrals to other essential
health and human services (e.g., substance use treatment programs, basic medical
care, etc.) that may help address unmet needs and facilitate substance use cessation.6,
7
In order for SEPs to be efﬁcacious, their services must be accessible to the PWID
population. Existing literature has shown that PWID who reside greater than 1 mi
from a SEP are more likely to have injected with a used syringe in the prior
6 months.8 Research has also documented that persons who live within a 10-min
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walk to SEPs are nearly three times more likely to consistently access services than
their counterparts who live further away.9
SEP accessibility among injectors may be affected by structural and temporal
barriers; for example, in the District of Columbia (DC), a policy (§48-1121) was
passed in 2000 prohibiting the distribution of Bany needle or syringe for the
hypodermic injection of any illegal drug in any area of the District of Columbia
which is within 1000 feet of a public or private elementary or secondary school
(including a public charter school).^ Although no research has empirically examined
this policy in depth, it is possible that it restricts SEP operations in areas of greatest
need for syringe exchange services and forces PWID to travel greater distances to
engage with the SEP. Research has also identiﬁed limited hours of SEP operations as
a contributing factor to increased likelihood of syringe sharing.10
A study quantiﬁed the distances between SEPs and areas of relevance to PWID
(such as where substances are purchased/used and home residence); however, these
ﬁndings were based on data from 2002 to 2006 among the Philadelphia PWID
population.11 According to a recent study that examined SEP access among the
PWID population in the DC, active injectors traveled nearly 3 mi (on average) to
access SEP services in 2014.7 Notably, this study of DC injectors operationalized
SEP access as the distance PWID walked via sidewalks to engage with the SEP.
Though these studies offer valuable insights into SEP accessibility, they do not
examine how SEP access may change over time. This is an important gap in the
literature given that SEP accessibility may be a contributing factor for consistent
utilization of sterile injection equipment. The purpose of this research is to expand
our knowledge of SEP accessibility among the DC PWID population by examining
the distance PWID traveled to engage with Prevention Works, the city’s ﬁrst SEP,
from its implementation in 1996 to its closing in 2011. We hypothesized that the
average distance persons traveled from their home residence to the SEP would
decrease over time as the efﬁciency of the SEP increased.
METHODS
Exchange records from Prevention Works were used to estimate the walking
distance PWID traveled to access syringe exchange services from its implementation
to its closing. At the time of registration with the SEP, each client was assigned a
unique identiﬁer and asked questions pertaining to race/ethnicity, age, substance use
proﬁle, HIV status, and other sociodemographic measures. The unique identiﬁers
were used by the SEP to track the services each PWID accessed, how many syringes
they returned/were given, and where they accessed the SEP at each exchange event.
All exchange sites (public parks, intersections, shopping center parking lots, etc.)
were geocoded using Google Maps.12 Because home residence data were limited to
the zip code of residence, the geometric point distance estimation technique was used
to estimate the walking distance PWID traveled to access the SEP. In this technique,
distance measures are calculated using the geometric centroid (i.e., the geometric
center) of a given unit of analysis, such as a zip code or neighborhood, with the
assumption that all data pertaining to the unit of analysis have a common origin at
the centroid point.13–15 This methodological approach was used in a previous study
that examined differences in SEP access between active and non-active injectors.7
Map data of zip codes in the USA were downloaded from the United States Census
Bureau16 and imported to ArcMap v10.2.1. ArcMap was used to calculate the
latitude and longitude coordinates of the centroid point of each zip code.
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Because we sought to understand SEP access among DC PWID, any instances
where a person reported residing in a zip code outside of the District (thus indicating
a non-DC resident) or at a post ofﬁce box zip code (which may represent a location
of convenience rather than a space near the participant’s home) were excluded from
the analysis. A SAS macro was used to quantify the walking distance (via sidewalks)
between the centroid point of zip code of home residence and SEP exchange site. The
walking distance measures were then analyzed by calendar year. Analysis of
variance (ANOVA) was used to test for differences between the mean walking
distance measures by year. Because the SEP closed in February 2011, data were only
analyzed for years in which a complete calendar year of data was available (1996–
2010). The George Washington University Institutional Review Board approved this
study (IRB# 111421).
RESULTS
The Prevention Works database included records for 12,094 unique PWID who
accessed SEP services from 1996 to 2011. In total, these persons engaged in 77,221
exchanges. The number of exchanges that took place annually ranged from 485 to
14,285. To better understand SEP access among DC PWID and to make the analyses
more generalizable, a number of exclusion criteria were applied. The ﬁnal analytic
sample consisted of African-American/Black or Caucasian/White DC PWID who
reported being male or female and who reported residing at a geographic zip code
(rather than a post ofﬁce box zip code).
Among the 12,094 persons who engaged with the SEP, 54.3 % (n = 6571) had
registration data that included information pertaining to zip code of home residence.
Chi-square and t test analyses were used to compare PWID with and without zip
code of home residence data. Those who had home residence data were slightly
younger than those without residence data (41.5 and 42.7 years, respectively;
p G .05). A greater proportion of those with residence data identiﬁed as men
compared to those with missing residence data (73.1 and 68.4 %, respectively;
p G .001). Similarly, there were also differences between those with and without
residence data in terms of the proportion of PWID that identiﬁed as AfricanAmerican/Black (93.4 and 83.2 %, respectively; p G .001). Although these differences
were signiﬁcant, they are most likely reﬂective of inconsistent data collection at the
time PWID registered with the SEP. When persons presented for services, SEP
personnel may have focused more on the provision of sterile injection equipment
and referrals to other services rather than uniform and complete data collection.
Among those SEP clients with zip code of home residence data (n = 6571), a minority
of persons were excluded due to small sample sizes. For instance, 0.2 % (n = 15) were
excluded due to persons identifying as transgender. Transgender clients were also
excluded from the analytic sample as it is possible they accessed SEP services to obtain
injection equipment for injecting hormones or silicone rather than injecting drugs. An
additional 104 persons (1.6 %) were excluded due to missing gender data, leaving 6452
PWID in the preliminary analytic sample. Persons who identiﬁed as a race/ethnicity other
than African-American/Black or Caucasian/White were also excluded. This resulted in
the exclusion of a small number of PWID (n = 84); more speciﬁcally, it resulted in the
exclusion of n = 33 persons who identiﬁed as Hispanic, n = 9 persons who identiﬁed as
Asian, and n = 12 persons who identiﬁed as Bother^ (but without any further information
describing what constituted Bother^). Other persons (n = 30) were excluded from the
analyses due to missing race/ethnicity data. These exclusions left 6368 PWID in the
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preliminary analytic sample who identiﬁed as male or female and African-American/
Black or Caucasian/White.
The remaining PWID (n = 6368) in the sample reported zip codes of home
residence in seven different states (MD, VA, CA, MI, NE, CT, and LA) and DC,
although the majority (87.8 %, n = 5593) reported a DC zip code. Among those that
reported a non-DC zip code (n = 775), the majority (74.2 %, n = 575) reported a MD
zip code. Of these 575 persons from a MD zip code, the majority (89.7 %, n = 516)
reported a zip code in a county adjacent to DC, and these persons were dispersed
across 18 different zip codes in that county. Twenty-three percent (n = 179) of the
PWID outside DC reported a zip code in Virginia, and, similarly, they were
geographically dispersed across 15 different zip codes that varied substantially in
size and proximity to DC. Among the other ﬁve states represented in the data, no
state had more than 11 persons reporting a zip code of residence in the given state.
To tailor the analyses to DC PWID, only data from persons who reported a DC zip
code were included. This yielded 5593 PWID clients from zip codes (of any type) in
the District. These persons collectively engaged in 45,899 exchanges.
Among the remaining PWID, 76.9 % (n = 4300) had exchange location data that
was viable for geocoding for use in the distance estimation calculations (i.e., the
location(s) of the exchanges were able to be matched to a speciﬁc location). The
registration data that were not viable for geocoding stemmed from limitations in
how data were recorded in the Prevention Works dataset. More speciﬁcally, the
exchange locations that were coded as BVarious Sites^ or BUnidentiﬁed^ were not
able to be geocoded to a speciﬁc location and resulted in some persons having no
viable exchange data for the purposes of this study. Of the remaining 4300 PWID,
84.6 % (n = 3638) reported a zip code of home residence in DC that was a
geographical zip code (i.e., not a post ofﬁce box zip code). These 3638 persons and

TABLE 1

Descriptive statistics of the analytic sample (n = 3638)
% of
sample

Variable
Gender
Race
Housing status

Engagement in a drug treatment
program
Employment status

Education level

Male
Female
African-American/Black
White
Not marginally housed
Marginally housed
Missing housing data
Never in a drug treatment program
Previously in a drug treatment program
Unemployed
Employed part-time
Employed full-time
Missing employment data
Did not graduate high school
Graduated high school (no college)
Graduated high school (some college, no
degree)
Graduated from college
Missing education data

74.7
25.3
96.6
3.4
27.4
62.4
10.2
49.8
50.2
75.2
4.6
9.6
10.5
23.5
53.5
9.5
3.2
10.3
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Analytic sample substance use measures (n = 3638)

Substance

Reported use

Heroin

Did not report
Reported use
Did not report
Reported use
Did not report
Reported use
Did not report
Reported use

Skin popping
Cocaine
Speedball

% of sample
use

12.4
87.6
57.5
42.5
66.1
34.0
43.5
56.5

use
use
use

their collective 33,959 total exchange records formed the analytic sample for these
analyses.
The majority of the analytic sample identiﬁed as male (74.7 %) and AfricanAmerican/Black (96.6 %). The mean age at time of registration was 41.0 ± 8.8 years
(range 10–73 years). The majority also reported being marginally housed (62.4 %),
unemployed (75.2 %), and having completed high school, but not attended college
(53.5 %). Slightly more than half of the sample (50.2 %) reported having ever
engaged in a drug treatment program. In terms of substance use, the majority
reported using heroin (87.6 %) and speedball (56.5 %). These data are summarized
in Tables 1 and 2.
The SEP dataset did not include viable exchange data that could be used in the
distance estimations from 1999 to 2002; however, from 1996 to 1998, the average
walking distance between the centroid point of zip code of home residence and
exchange site decreased from 3.29 to 2.03 mi (p G .05). There were no statistically
signiﬁcant differences in the mean walking distance measures from 2003 to 2008.
During these years, the distance measure remained nearly constant, averaging
around 2.75 mi. Notably, the mean walking distance increased in the last two
complete years the SEP was open (2009 and 2010). More speciﬁcally, PWID
TABLE 3

Walking distance measures by year of exchange

Year of
exchange

Viable number of
exchanges

1996
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010

1105
3287
1649
0
0
0
0
2129
7062
5545
4320
3927
2602
836
1497

Mean walking distance
(mi)
3.29
2.93
2.03
0.00
0.00
0.00
0.00
2.75
2.74
2.76
2.81
2.74
2.80
3.51
4.02

Standard
deviation
1.70
1.66
1.81
0.00
0.00
0.00
0.00
1.94
1.96
1.99
2.03
2.01
2.09
2.21
2.24

Range
8.90
9.00
9.00
0.00
0.00
0.00
0.00
10.20
11.70
11.20
11.20
11.20
11.20
9.60
11.20

1996

G.0001
G.0001
G.0001
G.0001
G.0001
G.0001
G.0001
G.0001
0.376
G.0001

1996
1997
1998
2003
2004
2005
2006
2007
2008
2009
2010

G.0001
0.0332
0.0003
0.0028
0.1693
0.0012
0.246
G.0001
G.0001

1997

G.0001
G.0001
G.0001
G.0001
G.0001
G.0001
G.0001
G.0001

1998

1
1
0.9947
1
0.9995
G.0001
G.0001

2003

1
0.9088
1
0.992
G.0001
G.0001

2004

ANOVA comparisons of mean walking distance measures by year

Year

TABLE 4

0.9897
1
0.9996
G.0001
G.0001

2005

0.9038
1
G.0001
G.0001

2006

0.9863
G.0001
G.0001

2007

G.0001
G.0001

2008

G.0001

2009

2010
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reported traveling the furthest distances during these years (3.51 and 4.02 mi,
respectively). Notably, the estimated mean walking distance in 2010 was signiﬁcantly (p G .05) greater than all preceding year mean estimates. These data are
summarized in Tables 3 and 4 and depicted in Fig. 1.
DISCUSSION
These data provide limited support for the hypothesis that the average walking
distance PWID traveled to engage with SEPs would decrease over time. The
estimated mean walking distance by year decreased during the ﬁrst few years of
Prevention Works’ operations then remained relatively stationary (approximately
2.75 mi) from 2003 to 2008, but later increased to just over 4 mi in 2010. This
ﬁnding may be explained by the closing of Prevention Works: as the organization
began experiencing management and personnel problems, its service delivery
became less efﬁcient and/or unpredictable. In other words, the geographic diversity
and operational hours of the SEP exchange sites may have changed/decreased and
caused PWID to travel greater distances to access services.
As noted previously, a policy implemented in 2000 also exists in the District that
prohibits SEPs from operating within 1000 ft of a school. It is plausible that the
amount of legal SEP operational space changed over time and resulted in PWID
traveling greater distances to access services. Given that there were no viable data
for the 1999–2002 period, our ability to extrapolate the possible effects of this
policy restriction is limited. Future work should be conducted to examine this policy
restriction more in-depth and its possible effects on SEP accessibility. Work should
also be conducted among the DC PWID population to understand the possible
reasons that drove the shifts in commuting distance.
The results of this study align with similar measures of SEP access among PWID
in Philadelphia, PA. According to Williams and Metzger, the approximate distance
from home residence to SEP site was approximately 2.5 mi for the Philadelphia
PWID population who accessed SEP services from 2002 to 2006.11 There were
methodological differences between the study of Philadelphia PWID and this
research due to limitations in the available data, but the fact remains that the
approximate walking distance measures were comparable between the two cities’
PWID populations. Our ﬁndings also align with another DC-based study that found
that injectors were traveling approximately 2.75 mi to access SEP services in 2014.7
Together, this collective evidence addresses an important issue in the public health
Mean Walking Distance (miles)

5
4.02

4

3.51

3.29

3

2.93

2.75 2.74 2.76 2.81 2.74 2.8
2.03

2
1
0
1996

1998

2000

2002

2004

Year of Exchange

FIG. 1

Mean walking distance by year

2006

2008

2010
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literature by demonstrating that shifts in SEP access occurred in PWID populations
and that these shifts may be due to organization issues (e.g., changes in SEP
operations) rather than factors associated with PWID themselves. Future work
should explore the relationship between SEP accessibility and exchange patterns
among PWID.
The results of this study have a number of limitations that warrant discussion.
Foremost, the geometric point distance estimation method assumes that all persons
who report a given unit of analysis reside at a geometric centroid point. As noted in
a previous study of injectors’ access to SEP services that used this method, this
limitation is important Bgiven that gentriﬁcation and changes in residential and
commercial zoning may lead to uneven housing opportunities and population
distributions within a given zip code.^7 Secondarily, this study assessed walking
distance between zip code of home residence and exchange site. In actuality, it may
be the case that other points of interest are more salient in determining SEP
utilization (e.g., distance between location of drug purchase and SEP exchange site).
Another limitation of this research is that walking distance was measured rather
than distance via automobile or public transportation. Although these modes of
transportation may be used by some PWID who access SEP services, it is more likely
that majority of DC PWID access services via walking due to the ﬁnancial burdens
associated with private and public transportation.7 Future work should explore
what mode(s) of transit PWID most commonly use to access services and what
routes they take to reach the exchange site.
An additional limitation is that we were unable to determine the extent to which PWID
accessed sterile injection equipment via over-the-counter (OTC) purchase at pharmacies.
Research has shown that greater spatial access to SEPs and OTC syringe purchase at
pharmacies improved injectors’ capacity to engage in harm reduction practices.17
However, research has also found that the prevalence of OTC syringe purchase is 53 %
lower among African-American PWID.18 Given that persons reported traveling greater
distances in later years of the study period and that the majority of our analytic sample
identiﬁed as African-American, important next steps for this research are to examine the
prevalence of OTC syringe purchasing among DC PWID and to evaluate differences in
the risk proﬁles of PWID who only access sterile injection equipment at SEPs and those
who acquire syringes at both SEPs and pharmacies.
Lastly, data limitations forced these analyses to be based on the collective
exchange records of only a portion of the Prevention Works dataset. Given the brief
time that PWID engage with the SEP at each exchange event, it is logical that there
was a relatively large amount of data that were not viable for these analyses. It is
highly likely that when the SEP was in operations, they focused their efforts on
distributing sterile injection equipment and referrals rather than ensuring completeness of data collection. Despite these limitations, this study examines the collective
exchange activities of more than 3600 PWID over more than a decade and
contributes to our understanding of SEP accessibility.
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